Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].

Adam Z, Pour L, Krejcí M, Pourová E, Synek O, Zahradová L, Navrátil M, Mechl M, Nebeský T, Neubauer J, Feit J, Vokurková J, Král Z, Bednarík O, Slampa P, Dolezalová H, Hájek R, Mayer J.

Vnitr Lek. 2010 Aug;56(8):810-23. Review. Czech.

PMID:
20845613
2.

[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].

Adam Z, Krikavová L, Krejcí M, Mechl M, Pour L, Moulis M, Vanícek J, Neumann C, Navrátil M, Veselý K, Vorlícek J.

Vnitr Lek. 2008 Jun;54(6):653-64. Czech.

PMID:
18672578
3.

[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].

Adam Z, Pour L, Matýšková M, Krejčí M, Tomíška M, Szturz P, Rehák Z, Koukalová R, Křikavová L, Nebeský T, Neuman C, Navrátil M, Hájek R, Král Z, Mayer J.

Vnitr Lek. 2012 Feb;58(2):145-53. Czech.

PMID:
22463096
4.

[Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].

Adam Z, Matýšková M, Tomíška M, Rehák Z, Koukalová R, Křikavová L, Pour L, Krejčí M, Szturz P, Zahradová L, Mechl M, Moulis M, Vaníček J, Neuman C, Navrátil M, Veselý K, Hájek R, Mayer J.

Klin Onkol. 2012;25(1):47-62. Czech.

PMID:
22348220
5.

[Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].

Adam Z, Krejcí M, Pour L, Neubauer J, Prásek J, Hájek R.

Vnitr Lek. 2008 Dec;54(12):1140-53. Review. Czech.

PMID:
19140523
6.

[The benefit of new angiogenesis (bevacizumab and aflibercept) inhibitors for multiple angiomatosis therapy: a case report].

Brančíková D, Ostřížková L, Adam Z, Nebeský T, Pour L, Král Z, Mayer J.

Vnitr Lek. Fall 2017;63(10):672-678. Czech.

PMID:
29127751
7.

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM.

Urology. 2004 Jun;63(6):1061-5.

PMID:
15183950
8.

Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols.

Pacheco AV, Rasila K, Lee SJ, Rabinowitz I, Elias L, Lee FC, Verschraegen CF.

Urol Oncol. 2008 Nov-Dec;26(6):610-5. doi: 10.1016/j.urolonc.2007.09.001. Epub 2008 Mar 4.

PMID:
18367103
9.

[Teleangiectasia hereditaria haemorrhagica--Osler-Weber-Rendu syndrome. Case study and treatment experience].

Adam Z, Chlupová G, Neumann A, Jakubcová B, Simonides J, Adamová Z, König J, Krupa P, Szturz P, Pour L, Krejčí M, Hájek R, Král Z, Mayer J.

Vnitr Lek. 2012 Jun;58(6):477-89. Czech.

PMID:
22913241
10.

Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.

Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.

Hepatogastroenterology. 1998 Nov-Dec;45(24):2282-94.

PMID:
9951911
11.
12.

Use of simple hematological, biochemical and clinical parameters to monitor response of multiple myeloma patients on high dose thalidomide therapy.

Uppal G, Raina V, Sharma A, Anand M, Kumar R, Khaitan BK, Grover JK.

Indian J Cancer. 2005 Jan-Mar;42(1):46-50.

13.

[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].

Adam Z, Pour L, Krejčí M, Zahradová L, Szturz P, Koukalová R, Rehák Z, Nebeský T, Hájek R, Král Z, Mayer J.

Vnitr Lek. 2012 Nov;58(11):856-66. Review. Czech.

PMID:
23256832
14.

[Interferon alpha and infantile orbital hemangioma].

Damas Mateache B, Menéndez Suso JJ, Abelairas Gómez JM, Albajara Velasco L, Peralta Calvo J, Verdú Sánchez C, Royo Orejas A.

Arch Soc Esp Oftalmol. 2003 Nov;78(11):623-9. Spanish.

PMID:
14648369
15.

Thalidomide treatment of resistant or relapsed multiple myeloma patients.

Hus M, Dmoszynska A, Soroka-Wojtaszko M, Jawniak D, Legiec W, Ciepnuch H, Hellmann A, Wolska-Smolen T, Skotnicki A, Manko J; Polish Multiple Myeloma Study Group.

Haematologica. 2001 Apr;86(4):404-8.

16.

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.

Patt YZ, Hassan MM, Lozano RD, Nooka AK, Schnirer II, Zeldis JB, Abbruzzese JL, Brown TD.

Cancer. 2005 Feb 15;103(4):749-55.

17.

Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.

Harper L, Michel JL, Enjolras O, Raynaud-Mounet N, Rivière JP, Heigele T, De Napoli-Cocci S.

Eur J Pediatr Surg. 2006 Oct;16(5):369-72.

PMID:
17160787
18.

[A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].

Adam Z, Matýková M, Krejcí M, Pour L, Kissová J, Slechtová M, Chlupová G, Stavarová Y, Simonides J, Penka M, Mayer J, Hájek R.

Vnitr Lek. 2010 Jan;56(1):67-78. Review. Czech.

PMID:
20184115
19.

Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.

Ciepłuch H, Baran W, Hellmann A.

Med Sci Monit. 2002 Apr;8(4):PI31-6.

PMID:
11951079
20.

Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.

Offidani M, Corvatta L, Polloni C, Piersantelli MN, Gentili S, Galieni P, Visani G, Alesiani F, Catarini M, Brunori M, Samori A, Burattini M, Centurioni R, Ferranti M, Giuliodori L, Candela M, Mele A, Marconi M, Leoni P.

Br J Haematol. 2009 Mar;144(5):653-9. doi: 10.1111/j.1365-2141.2008.07495.x. Epub 2008 Nov 13.

PMID:
19036082

Supplemental Content

Support Center